2010
DOI: 10.1007/s12253-010-9249-7
|View full text |Cite
|
Sign up to set email alerts
|

Uterine Tumors with Neuroectodermal Differentiation. A Report of 4 Cases

Abstract: We report four cases of uterine tumors with neuroectodermal differentiation. One tumor had neuroectodermal component only; in the three other tumors, the neuroectodermal component was admixed with another component, namely rhabdomyosarcoma (1 case), and endometrioid adenocarcinoma (2 cases). Histologically, the neuroectodermal component consisted of small to medium sized cells arranged in diffuse sheets. The tumor cells had round nuclei with stippled to coarsely granular chromatin, mostly with non-prominent nu… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
13
0

Year Published

2010
2010
2020
2020

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 14 publications
(13 citation statements)
references
References 35 publications
0
13
0
Order By: Relevance
“…The present review of the literature yielded 30 cases of uterine PNET combined with other malignancies ( Table 2). Other than adenosarcoma (two cases) [4,8], PNET have been found admixed with endometrioid endometrial carcinoma (15 cases) [4,[9][10][11][12], malignant mixed Müllerian tumour (MMMT) (two cases) [4], high grade serous endometrial carcinoma (five cases) [12], rhabdomyosarcoma (four cases) [4,9,[13][14], and endometrial stromal sarcoma (two cases) [4,10]. A Müllerian derivation for at least some of these uterine PNET has been advocated, due to the prevalence of cases associated with a Müllerian neoplasm (Table 2).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The present review of the literature yielded 30 cases of uterine PNET combined with other malignancies ( Table 2). Other than adenosarcoma (two cases) [4,8], PNET have been found admixed with endometrioid endometrial carcinoma (15 cases) [4,[9][10][11][12], malignant mixed Müllerian tumour (MMMT) (two cases) [4], high grade serous endometrial carcinoma (five cases) [12], rhabdomyosarcoma (four cases) [4,9,[13][14], and endometrial stromal sarcoma (two cases) [4,10]. A Müllerian derivation for at least some of these uterine PNET has been advocated, due to the prevalence of cases associated with a Müllerian neoplasm (Table 2).…”
Section: Discussionmentioning
confidence: 99%
“…Gersell et al and Fukunaga et al cases contained mature neural elements such as ganglion cells, or glia, and expressed GFAP, which is not a feature of PNET [15,16]. Rare cases of combined rhabdomyosarcoma and PNET have been also described [4,9,13,14] ( Table 2).…”
Section: Discussionmentioning
confidence: 99%
“…Reports with incomplete information about chemotherapy were also excluded. Of a total of 178 papers identified from the search terms in the MEDLINE database, 49 cases fulfilled the mentioned criteria (Table ). We analyzed the choice of chemotherapy regimen in relation to the patients’ ages and divided patients into the following groups: adolescence (<20 years), reproductive (20–40 years), premenopausal (40–60 years) and elderly (>60 years).…”
Section: Discussionmentioning
confidence: 99%
“…1B), as are numerous mitotic figures, including atypical forms. Combining data from the series of Dundr et al 55 and Euscher et al 57 yields the immunophenotypic profile outlined in Table 2. The differential diagnosis for uterine ES/PNET is extensive, and is beyond the scope of this contribution.…”
Section: Angiosarcomamentioning
confidence: 99%
“…67,68 In uterine ES/PNET, however, rearrangements in the EWSR1 gene have only been found in 4 (20%) of the 20 tested cases. 41,48,55,57,58 In the author's opinion, the tumors that have been referred to as ES/PNET of the uterus, although morphologically similar, are histogenetically heterogeneous. In a small subset, probably approximately 20%, they are akin to typical, peripheral, osseous-type ES/PNET, and this is the group displaying EWSR1 rearrangements.…”
Section: Angiosarcomamentioning
confidence: 99%